+467.0%
MRNA vs FFIV
+26.0%
+441.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | FFIV | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +3.3% | +2.1% | +5.8% |
| 7D | -1.1% | +5.4% | -6.5% | -0.4% |
| 30D | +126.1% | -2.7% | +128.8% | +132.3% |
| 3M | +190.0% | +4.5% | +185.5% | +191.2% |
| 6M | +157.2% | +42.2% | +115.0% | +132.9% |
| YTD | +388.2% | +61.3% | +326.9% | +316.6% |
| 1Y | +467.0% | +23.0% | +444.0% | +417.4% |
| All | +467.0% | +26.0% | +441.0% | +417.4% |
Cumulative growth
Daily Returns
Daily percentage return beside FFIV.
Daily Out/Under-Performance
Portfolio return minus FFIV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FFIV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded FFIV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling